Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03709316 | A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer | unknown | Phase 3 | 384 | Zai Lab (Shanghai) Co., Ltd.INDUSTRY | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04911114 | Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian Cancer(BE-BALANCED) | unknown | N/A | 30 | University of British ColumbiaOTHER | 1 | Jun 2, 2021 |
| clinicaltrials |
| NCT04836663 | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors | unknown | Phase 2 | 90 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04556669 | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors | unknown | Phase 1 | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT04395612 | Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer(CQGOG0101) | unknown | Phase 2 | 38 | Chongqing University Cancer HospitalOTHER | 1 | May 21, 2021 | clinicaltrials |
| NCT04117594 | Whole Body Magnetic Resonance Imaging Study(WISE) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT04891536 | Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy(CRIOAND2021) | unknown | N/A | 100 | Ignacio Puche SanzOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT04628806 | Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells(HSP70CTC) | unknown | — | 120 | Charite University, Berlin, GermanyOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT03676959 | A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer | unknown | Phase 1 | 101 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 13, 2021 | clinicaltrials |
| NCT04884906 | Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT04556539 | Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer | unknown | Phase 2 | 104 | Jiangxi Qingfeng Pharmaceutical Co. Ltd.INDUSTRY | 1 | May 12, 2021 | clinicaltrials |
| NCT04882618 | Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. | unknown | Phase 4 | 50 | TC Erciyes UniversityOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT03431753 | Early and Accurate Detection of Prostate Cancer in General Practice | unknown | N/A | 3,000 | Aarhus University HospitalOTHER | 1 | May 4, 2021 | clinicaltrials |
| NCT03852823 | Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours | unknown | Phase 1 | 192 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04868097 | Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2 | unknown | N/A | 52 | Kaplan Medical CenterOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT00703105 | Ovarian Dendritic Cell Vaccine Trial | unknown | Phase 2 | 36 | Loyola UniversityOTHER | 1 | Apr 26, 2021 | clinicaltrials |
| NCT03440554 | Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization | unknown | N/A | 150 | University of California, San DiegoOTHER | 1 | Apr 26, 2021 | clinicaltrials |
| NCT04846842 | A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | unknown | Phase 2 | 46 | Lee's Pharmaceutical LimitedINDUSTRY | 0 | Apr 19, 2021 | clinicaltrials |
| NCT03396848 | Sexual Health and Rehabilitation eClinic (SHAReClinic) | unknown | N/A | 65 | University Health Network, TorontoOTHER | 1 | Apr 14, 2021 | clinicaltrials |
| NCT03876912 | The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer(ADTPSMA2) | unknown | N/A | 35 | Turku University HospitalOTHER_GOV | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03770351 | Early Prostate Cancer: Predicting Treatment Response | unknown | — | 693 | University of California, IrvineOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04839055 | The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC(CoA-CRPC) | unknown | Phase 1 / Phase 2 | 50 | Jiangnan UniversityOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04337632 | Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer | unknown | Phase 3 | 338 | Hunan Cancer HospitalOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04828616 | Study of DP303c Injection in Patients With Advanced Ovarian Cancer | unknown | Phase 2 | 104 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 2, 2021 | clinicaltrials |
| NCT04825002 | Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor | unknown | N/A | 800 | Asan Medical CenterOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04819685 | Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury | unknown | Phase 4 | 520 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT00653848 | Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy(AdRad) | unknown | Phase 3 | 378 | Scandinavian Prostate Cancer GroupNETWORK | 1 | Mar 25, 2021 | clinicaltrials |
| NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer(EMBRACE) | unknown | — | 1,416 | Medical University of ViennaOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT04815408 | PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer | unknown | Phase 2 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT04812938 | Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test(PAPAudit) | unknown | — | 190 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03000192 | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | unknown | — | 3,000 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04461574 | Orcellex® Brush Versus Cervex-Brush® on Vault Smear Adequacy in Patients Treated With Radiotherapy for Cervical Cancer | unknown | N/A | 160 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04783636 | To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers | unknown | Phase 1 | 40 | Peptron, Inc.INDUSTRY | 0 | Mar 17, 2021 | clinicaltrials |
| NCT04803188 | Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I(ProSa-I) | unknown | N/A | 710 | University of Roma La SapienzaOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04068974 | Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer | unknown | Phase 2 | 28 | Peking Union Medical College HospitalOTHER | 1 | Mar 16, 2021 | clinicaltrials |
| NCT04800978 | Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 0 | Mar 16, 2021 | clinicaltrials |
| NCT04789941 | How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix | unknown | Phase 2 | 50 | Assiut UniversityOTHER | 0 | Mar 10, 2021 | clinicaltrials |
| NCT04792138 | Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.(Histo-MRI) | unknown | — | 300 | University College, LondonOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT02623647 | A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer(eHYPO) | unknown | N/A | 150 | Regina Elena Cancer InstituteOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT04579861 | GO SOAR1: Post-Operative Morbidity and Mortality Following Gynaecological Oncology Surgery(GO SOAR1) | unknown | — | 1,100 | Faiza GabaOTHER_GOV | 1 | Mar 9, 2021 | clinicaltrials |
| NCT04787159 | Endometrial Cancer International Database(ECID) | unknown | — | 1,000 | Assiut UniversityOTHER | 0 | Mar 9, 2021 | clinicaltrials |
| NCT04783649 | Clinical Validation of Cervical Cancer Screening Methods | unknown | — | 2,500 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04400942 | Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy | unknown | — | 600 | Ospedale Policlinico San MartinoOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT03808857 | A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive | unknown | Phase 2 | 80 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Mar 3, 2021 | clinicaltrials |
| NCT03520478 | A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer | unknown | Phase 3 | 654 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 4 | Mar 2, 2021 | clinicaltrials |
| NCT03943602 | Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)(CaboPen) | unknown | Phase 2 | 37 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT02944201 | Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | unknown | Phase 2 | 22 | Montefiore Medical CenterOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT00955435 | Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | unknown | — | 60 | Cancer Trials IrelandNETWORK | 1 | Feb 18, 2021 | clinicaltrials |
| NCT02895854 | LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients(BRAVEROBO) | unknown | N/A | 44 | Kuopio University HospitalOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT04748978 | OPPIuM Technique and Myolysis With Diode Laser Dwls(Myolysis) | unknown | N/A | 35 | University of CagliariOTHER | 1 | Feb 15, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jun 2, 2021source: clinicaltrials